Literature DB >> 4210686

Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.

E Garelis, T L Sourkes.   

Abstract

Concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were significantly higher in CSF obtained after injection of air during pneumoencephalography (PEG) than in lumbar CSF, as drawn before the injection. There was a high correlation between levels in the `mixed' and lumbar samples of CSF in the case of each of the two acids. The concentration of lumbar HVA, but not that of 5-HIAA, was negatively correlated with CSF pressure. 5-HIAA levels were low in both samples of CSF in a group of epileptics, by comparison with controls. In two patients with Kufs disease and in one with Niemann-Pick disease, the concentration of HVA was very low in the lumbar sample. The application of a standardized PEG technique in the study of monoamine metabolism in man is suggested.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4210686      PMCID: PMC494750          DOI: 10.1136/jnnp.37.6.704

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

Authors:  G W Ashcroft; T B Crawford; D Eccleston; D F Sharman; E J MacDougall; J B Stanton; J K Binns
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

3.  [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz
Journal:  Wien Klin Wochenschr       Date:  1966-06-10       Impact factor: 1.704

4.  The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.

Authors:  H Anderson; B E Roos
Journal:  J Pharm Pharmacol       Date:  1968-11       Impact factor: 3.765

5.  A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid.

Authors:  D Eccleston; G W Ashcroft; A T Moir; A Parker-Rhodes; W Lutz; D P O'Mahoney
Journal:  J Neurochem       Date:  1968-09       Impact factor: 5.372

6.  On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism.

Authors:  H C Guldberg; J W Turner; A Hanieh; G W Ashcroft; T B Crawford; W L Perry; F J Gillingham
Journal:  Confin Neurol       Date:  1967

7.  [On the diagnostic value of homovanillic acid in the cerebrospinal fluid].

Authors:  G S Barolin; O Hornykiewicz
Journal:  Wien Klin Wochenschr       Date:  1967-11-03       Impact factor: 1.704

8.  The effect of some psychoactive drugs on central monoamine neurons.

Authors:  H Corrodi; K Fuxe; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1967-09       Impact factor: 4.432

9.  Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

Authors:  A Pletscher; G Bartholini; R Tissot
Journal:  Brain Res       Date:  1967-02       Impact factor: 3.252

10.  The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.

Authors:  G W Ashcroft; R C Dow; A T Moir
Journal:  J Physiol       Date:  1968-12       Impact factor: 5.182

View more
  7 in total

1.  CSF gradients for amino acid neurotransmitters.

Authors:  P M Crawford; K G Lloyd; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

2.  Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography.

Authors:  A Spissu; S Congia; M P Piccardi; F Fadda; A Mangoni; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice.

Authors:  M Hiramatsu
Journal:  Neurochem Res       Date:  1983-09       Impact factor: 3.996

4.  Catecholamine level in cerebrospinal fluid of epileptics.

Authors:  M Hiramatsu; N Fujimoto; A Mori
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

5.  Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.

Authors:  S N Young; S Gauthier; G M Anderson; W C Purdy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

6.  Studies on cyclic AMP in different compartments of cerebrospinal fluid.

Authors:  D Tsang; S Lal; T L Sourkes; R M Ford; A Aronoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

7.  CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.

Authors:  J Malm; B Kristensen; J Ekstedt; P Wester
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.